Multispecific antibodies targeting IGF-1r and il-6 and uses thereof

TW202633919APending Publication Date: 2026-08-16INNOVENT BIOLOGICS (SUZHOU) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114142656
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-04
Filing Date
2025-11-03
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001072896_001
    Figure TWG2TA001072896_001
  • Figure TWG2TA001072896_002
    Figure TWG2TA001072896_002
  • Figure TWG2TA001072896_003
    Figure TWG2TA001072896_003
Patent Text Reader

Abstract

The present application provides novel multispecific antibody agents (e.g., bispecific antibody agents) that specifically bind to IGF-1R and IL-6. Further provided are pharmaceutical compositions thereof, methods of use (e.g., treating an autoimmune disease or fibrosis), methods of producing the multispecific antibody agents, and kits comprising the multispecific antibody agents.
Need to check novelty before this filing date? Find Prior Art